Summary
Pharmaceuticals in France industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The French pharmaceuticals market had total revenues of $32.6bn in 2020, representing a compound annual rate of change (CARC) of -1.5% between 2016 and 2020.
- The French government’s decision to increase its focus on the use of generic medicines to reduce healthcare spending has resulted in decreasing volumes and a downward pricing pressure on existing drugs.
- Reimbursement is based on external reference pricing linked to other EU countries, such as the UK’s NHS. Price reduction in these countries is immediately reflected in the price reductions in France, which has resulted in decreased healthcare spending and a declining pharmaceutical market.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in France
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in France
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the France pharmaceuticals market with five year forecasts by both value and volume
Reasons to Buy
- What was the size of the France pharmaceuticals market by value in 2020?
- What will be the size of the France pharmaceuticals market in 2025?
- What factors are affecting the strength of competition in the France pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in France's pharmaceuticals market?
'
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Market share
7.2. Who are the leading players?
7.3. What strategies do leading players follow?
7.4. What challenges are currently being faced by leading players?
8 Company Profiles
8.1. Sanofi SA
8.2. Laboratoires Pierre Fabre SA
8.3. AstraZeneca PLC
8.4. Les Laboratoires Servier
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: France pharmaceuticals market value: $ billion, 2016-20
Table 2: France pharmaceuticals market geography segmentation: $ billion, 2020
Table 3: France pharmaceuticals market value forecast: $ billion, 2020-25
Table 4: France pharmaceuticals market share: % share, by value, 2020
Table 5: Sanofi SA: key facts
Table 6: Sanofi SA: Annual Financial Ratios
Table 7: Sanofi SA: Key Employees
Table 8: Sanofi SA: Key Employees Continued
Table 9: Laboratoires Pierre Fabre SA: key facts
Table 10: Laboratoires Pierre Fabre SA: Key Employees
Table 11: AstraZeneca PLC: key facts
Table 12: AstraZeneca PLC: Annual Financial Ratios
Table 13: AstraZeneca PLC: Key Employees
Table 14: Les Laboratoires Servier: key facts
Table 15: Les Laboratoires Servier: Key Employees
Table 16: France size of population (million), 2016-20
Table 17: France gdp (constant 2005 prices, $ billion), 2016-20
Table 18: France gdp (current prices, $ billion), 2016-20
Table 19: France inflation, 2016-20
Table 20: France consumer price index (absolute), 2016-20
Table 21: France exchange rate, 2016-20
List of Figures
Figure 1: France pharmaceuticals market value: $ billion, 2016-20
Figure 2: France pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 3: France pharmaceuticals market value forecast: $ billion, 2020-25
Figure 4: Forces driving competition in the pharmaceuticals market in France, 2020
Figure 5: Drivers of buyer power in the pharmaceuticals market in France, 2020
Figure 6: Drivers of supplier power in the pharmaceuticals market in France, 2020
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2020
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2020
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in France, 2020
Figure 10: France pharmaceuticals market share: % share, by value, 2020
